HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Obesity as a risk factor for sedation-related complications during propofol-mediated sedation for advanced endoscopic procedures.

AbstractBACKGROUND:
There are limited data on the safety of anesthesia-assisted endoscopy by using propofol-mediated sedation in obese individuals undergoing advanced endoscopic procedures (AEPs).
OBJECTIVE:
To study the association between obesity (as measured by body mass index [BMI]) and the frequency of sedation-related complications (SRCs) in patients undergoing AEPs.
DESIGN:
Prospective cohort study.
SETTING:
Tertiary referral center.
PATIENTS:
A total of 1016 consecutive patients undergoing AEPs (BMI <30, 730 [72%]; 30-35, 159 [16%]; >35, 127 [12%]).
INTERVENTION:
Monitored anesthesia sedation with propofol alone or in combination with benzodiazepines and/or opioids.
MAIN OUTCOME MEASUREMENTS:
SRCs, airway maneuvers (AMs), hypoxemia, hypotension requiring vasopressors, and early procedure termination were compared across 3 groups.
RESULTS:
There were 203 AMs in 13.9% of patients, hypoxemia in 7.3%, need for vasopressors in 0.8%, and premature termination in 0.6% of patients. Increasing BMI was associated with an increased frequency of AMs (BMI <30, 10.5%; 30-35, 18.9%; >35-26.8%; P < .001) and hypoxemia (BMI <30, 5.3%; 30-35, 9.4%; >35, 13.4%; P = .001); there was no difference in the frequency of need for vasopressors (P = .254) and premature termination of procedures (P = .401). On multivariable analysis, BMI (odds ratio [OR] 2.0; 95% CI, 1.3-3.1), age (OR 1.1; 95% CI, 1.0-1.1), and American Society of Anesthesiologists class 3 or higher (OR 2.4; 95% CI, 1.1-5.0) were independent predictors of SRCs. In obese individuals (n = 286), there was no difference in the frequency of SRCs in patients receiving propofol alone or in combination (P = .48).
LIMITATIONS:
Single tertiary center study.
CONCLUSIONS:
Although obesity was associated with an increased frequency of SRCs, propofol sedation can be used safely in obese patients undergoing AEPs when administered by trained professionals.
AuthorsSachin Wani, Riad Azar, Christine E Hovis, Robert M Hovis, Gregory A Cote, Matthew Hall, Lawrence Waldbaum, Vladimir Kushnir, Dayna Early, Daniel K Mullady, Faris Murad, Steven A Edmundowicz, Sreenivasa S Jonnalagadda
JournalGastrointestinal endoscopy (Gastrointest Endosc) Vol. 74 Issue 6 Pg. 1238-47 (Dec 2011) ISSN: 1097-6779 [Electronic] United States
PMID22136773 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2011 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.
Chemical References
  • Anesthetics, Intravenous
  • Propofol
Topics
  • Aged
  • Anesthetics, Intravenous (administration & dosage)
  • Body Mass Index
  • Conscious Sedation (adverse effects)
  • Digestive System Diseases (complications, diagnosis)
  • Endoscopy, Gastrointestinal (methods)
  • Endosonography (methods)
  • Female
  • Follow-Up Studies
  • Humans
  • Hypotension (epidemiology, etiology)
  • Hypoxia (epidemiology, etiology)
  • Incidence
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Obesity (complications)
  • Odds Ratio
  • Propofol (administration & dosage)
  • Prospective Studies
  • Risk Factors
  • United States (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: